Status:
RECRUITING
Polish Multicenter PERTs PE Outcomes Registry
Lead Sponsor:
Poznan University of Medical Sciences
Collaborating Sponsors:
Polish Cardiac Society
Conditions:
Pulmonary Embolism With Acute Cor Pulmonale
Eligibility:
All Genders
18+ years
Brief Summary
Pulmonary embolism (PE) is the third leading cause of cardiovascular mortality. The Pulmonary Embolism Response Team (PERT) concept offers a rapid and multidisciplinary approach focused on improving o...
Detailed Description
Pulmonary embolism (PE) is the third leading cause of cardiovascular mortality. The presentation of PE may vary from asymptomatic or mild exertion disturbances (low-risk PE) treated with anticoagulant...
Eligibility Criteria
Inclusion
- PE confirmed by computed tomography pulmonary angiography.
- PE symptoms duration ≤ 14 days.
- High-risk PE with hemodynamic instability (one of):
- cardiac arrest
- obstructive shock
- persistent hypotension.
- Intermediate-high risk PE patients with right ventricle dysfunction confirmed by imaging studies and elevated troponin level.
Exclusion
- 1\. Refusal to sign the informed consent form.
Key Trial Info
Start Date :
June 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2030
Estimated Enrollment :
10000 Patients enrolled
Trial Details
Trial ID
NCT04879069
Start Date
June 1 2018
End Date
December 1 2030
Last Update
May 10 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Poznan University of Medical Sciences
Poznan, GreaterPoland, Poland, 61-848